English

CISTRON BIOTECHNOLOGY INC

EDGAR

Annual report (10-K) · filed 2000-09-07

20 filing records in this dataset, filed from 1996-05-13 to 2000-09-07. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

503 thousand USD

2000-06-30 · USD

Exact inputs and evidence

Revenue: 555205 USD Source
Revenue: 52690 USD Source

Operating margin

-63.18%

2000-06-30 · %

Exact inputs and evidence

Operating Income: -1341373 USD Source
Operating Income: -1023872 USD Source
Revenue: 555205 USD Source
Revenue: 52690 USD Source

Operating cash flow

-1.65 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -140500 USD Source
Operating Cash Flow: 1506383 USD Source

Cash and cash equivalents: 5.83 million USD 2000-06-30 Source
Exact value

5832031 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

555 thousand USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Revenue: 51310 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 1380 USD · 1999-10-01 – 1999-12-31 Source
Revenue: 0 USD · 2000-01-01 – 2000-03-31 Source
Revenue: 555205 USD · 1999-07-01 – 2000-06-30 Source
Revenue: 52690 USD · 1999-07-01 – 2000-03-31 Source

Net income

-476 thousand USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Net income: -186154 USD · 1999-07-01 – 1999-09-30 Source
Net income: -391387 USD · 1999-10-01 – 1999-12-31 Source
Net income: -157316 USD · 2000-01-01 – 2000-03-31 Source
Net income: -476479 USD · 1999-07-01 – 2000-06-30 Source
Net income: -734858 USD · 1999-07-01 – 2000-03-31 Source

Capital expenditure

4.65 thousand USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Capital expenditure: 0 USD · 1998-07-01 – 1998-12-31 Source
Capital expenditure: 0 USD · 1998-07-01 – 1998-09-30 Source
Capital expenditure: 2146 USD · 1998-07-01 – 1999-03-31 Source
Capital expenditure: 0 USD · 1998-07-01 – 1998-12-31 Source
Capital expenditure: 4649 USD · 1998-07-01 – 1999-06-30 Source
Capital expenditure: 2146 USD · 1998-07-01 – 1999-03-31 Source
Capital expenditure: 0 USD · 1999-07-01 – 1999-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-09-07.

Financial data available through: 2000-06-30.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2000-06-30
Operating income: 6 of 11 periods available· newest 2000-06-30
Net income: 6 of 11 periods available· newest 2000-06-30
Operating cash flow: 6 of 11 periods available· newest 2000-06-30
Capital expenditure: 5 of 11 periods available· newest 1999-06-30
Total assets: 5 of 11 periods available· newest 2000-06-30
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2000-06-30
Current liabilities: 6 of 11 periods available· newest 2000-06-30
Cash and cash equivalents: 6 of 11 periods available· newest 2000-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+64.9%

Prior period

USD 336,752

1998-07-01 – 1999-06-30
Current period

USD 555,205

1999-07-01 – 2000-06-30

Exact inputs and evidence

555205 − 336752 = 218453 USD

336752 USD · 1998-07-01 – 1999-06-30
Inspect prior input Prior source
555205 USD · 1999-07-01 – 2000-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CISTRON BIOTECHNOLOGY INC · 2000-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Year-over-year change in Revenue: 218453 USD Concept: fundies:Revenue Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 555205 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-00-000017.txt#2289 Input fundies:Revenue: 336752 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2214
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 199,315

Prior period

−USD 277,164

1998-07-01 – 1999-06-30
Current period

−USD 476,479

1999-07-01 – 2000-06-30

Exact inputs and evidence

-476479 − -277164 = -199315 USD

-277164 USD · 1998-07-01 – 1999-06-30
Inspect prior input Prior source
-476479 USD · 1999-07-01 – 2000-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CISTRON BIOTECHNOLOGY INC · 2000-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Year-over-year change in Net income: -199315 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -476479 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-00-000017.txt#2547 Input fundies:NetIncome: -277164 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2472
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-107%

Prior period

USD 2 million

1998-07-01 – 1999-06-30
Current period

−USD 140,500

1999-07-01 – 2000-06-30

Exact inputs and evidence

-140500 − 2002447 = -2142947 USD

2002447 USD · 1998-07-01 – 1999-06-30
Inspect prior input Prior source
-140500 USD · 1999-07-01 – 2000-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CISTRON BIOTECHNOLOGY INC · 2000-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Year-over-year change in Operating cash flow: -2142947 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -140500 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-00-000017.txt#2572 Input fundies:OperatingCashFlow: 2002447 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 1999-07-01 – 2000-06-30

Revenue USD 555,205 100% of revenue
Operating costs Derived USD 1.9 million 342% of revenue
Operating income −USD 1.34 million −242% of revenue
Tax, interest and other Derived −USD 864,894 −156% of revenue
Net income −USD 476,479 −86% of revenue

Cash

Operating cash flow −USD 140,500 −25% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Net income was higher than operating income, so the split is not drawn.
1996 Operating loss: operating costs were 302% of revenue.
1997 Net income was higher than operating income, so the split is not drawn.
1998 Operating loss: operating costs were 342% of revenue.
1999 Operating loss: operating costs were 381% of revenue.
2000 Operating loss: operating costs were 342% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1994-07-01 – 1995-06-30	649949	373538 Derived	276411	-2865 Derived	279276	736882 Derived	Source 1994-07-01 – 1995-06-30: 649949 USD Inspect Revenue Open source 1994-07-01 – 1995-06-30: 276411 USD Inspect Operating Income Open source 1994-07-01 – 1995-06-30: 279276 USD Inspect Net Income Open source 1994-07-01 – 1995-06-30: 736882 USD Inspect Operating Cash Flow Open source 1994-07-01 – 1995-06-30: 0 USD Inspect Capital Expenditure Open source
1996 1995-07-01 – 1996-06-30	562161	1695246 Derived	-1133085	-26919 Derived	-1106166	-531552 Derived	Source 1995-07-01 – 1996-06-30: 562161 USD Inspect Revenue Open source 1995-07-01 – 1996-06-30: -1133085 USD Inspect Operating Income Open source 1995-07-01 – 1996-06-30: -1106166 USD Inspect Net Income Open source 1995-07-01 – 1996-06-30: -525983 USD Inspect Operating Cash Flow Open source 1995-07-01 – 1996-06-30: 5569 USD Inspect Capital Expenditure Open source
1997 1996-07-01 – 1997-06-30	620180	-12986320 Derived	13606500	1260546 Derived	12345954	6238274 Derived	Source 1996-07-01 – 1997-06-30: 620180 USD Inspect Revenue Open source 1996-07-01 – 1997-06-30: 13606500 USD Inspect Operating Income Open source 1996-07-01 – 1997-06-30: 12345954 USD Inspect Net Income Open source 1996-07-01 – 1997-06-30: 6267437 USD Inspect Operating Cash Flow Open source 1996-07-01 – 1997-06-30: 29163 USD Inspect Capital Expenditure Open source
1998 1997-07-01 – 1998-06-30	555205	1896578 Derived	-1341373	-864894 Derived	-476479	-144426 Derived	Source 1997-07-01 – 1998-06-30: 555205 USD Inspect Revenue Open source 1997-07-01 – 1998-06-30: -1341373 USD Inspect Operating Income Open source 1997-07-01 – 1998-06-30: -476479 USD Inspect Net Income Open source 1997-07-01 – 1998-06-30: -140500 USD Inspect Operating Cash Flow Open source 1997-07-01 – 1998-06-30: 3926 USD Inspect Capital Expenditure Open source
1999 1998-07-01 – 1999-06-30	336752	1284601 Derived	-947849	-670685 Derived	-277164	1997798 Derived	Source 1998-07-01 – 1999-06-30: 336752 USD Inspect Revenue Open source 1998-07-01 – 1999-06-30: -947849 USD Inspect Operating Income Open source 1998-07-01 – 1999-06-30: -277164 USD Inspect Net Income Open source 1998-07-01 – 1999-06-30: 2002447 USD Inspect Operating Cash Flow Open source 1998-07-01 – 1999-06-30: 4649 USD Inspect Capital Expenditure Open source
2000 1999-07-01 – 2000-06-30	555205	1896578 Derived	-1341373	-864894 Derived	-476479	Unavailable	Source 1999-07-01 – 2000-06-30: 555205 USD Inspect Revenue Open source 1999-07-01 – 2000-06-30: -1341373 USD Inspect Operating Income Open source 1999-07-01 – 2000-06-30: -476479 USD Inspect Net Income Open source 1999-07-01 – 2000-06-30: -140500 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 555.2K 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-06-30	Revenue	649949	Revenue: 649949 Open source
19961996-06-30	Revenue	562161	Revenue: 562161 Open source
19971997-06-30	Revenue	620180	Revenue: 620180 Open source
19981998-06-30	Revenue	555205	Revenue: 555205 Open source
19991999-06-30	Revenue	336752	Revenue: 336752 Open source
20002000-06-30	Revenue	555205	Revenue: 555205 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

64.9% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-06-30	Year over year	No prior comparable period	Revenue: 649949 Open source
19961996-06-30	Year over year	-13.5%	Revenue: 562161 Open source Revenue: 649949 Open source
19971997-06-30	Year over year	10.3%	Revenue: 620180 Open source Revenue: 562161 Open source
19981998-06-30	Year over year	-10.5%	Revenue: 555205 Open source Revenue: 620180 Open source
19991999-06-30	Year over year	-39.3%	Revenue: 336752 Open source Revenue: 555205 Open source
20002000-06-30	Year over year	64.9%	Revenue: 555205 Open source Revenue: 336752 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -241.6% 2000

Net margin -85.8% 2000

Free cash flow margin 593.3% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-06-30	Operating margin	42.5%	Operating Income: 276411 Open source Revenue: 649949 Open source
19961996-06-30	Operating margin	-201.6%	Operating Income: -1133085 Open source Revenue: 562161 Open source
19971997-06-30	Operating margin	2,194%	Operating Income: 13606500 Open source Revenue: 620180 Open source
19981998-06-30	Operating margin	-241.6%	Operating Income: -1341373 Open source Revenue: 555205 Open source
19991999-06-30	Operating margin	-281.5%	Operating Income: -947849 Open source Revenue: 336752 Open source
20002000-06-30	Operating margin	-241.6%	Operating Income: -1341373 Open source Revenue: 555205 Open source
19951995-06-30	Net margin	43%	Net Income: 279276 Open source Revenue: 649949 Open source
19961996-06-30	Net margin	-196.8%	Net Income: -1106166 Open source Revenue: 562161 Open source
19971997-06-30	Net margin	1,990.7%	Net Income: 12345954 Open source Revenue: 620180 Open source
19981998-06-30	Net margin	-85.8%	Net Income: -476479 Open source Revenue: 555205 Open source
19991999-06-30	Net margin	-82.3%	Net Income: -277164 Open source Revenue: 336752 Open source
20002000-06-30	Net margin	-85.8%	Net Income: -476479 Open source Revenue: 555205 Open source
19951995-06-30	Free cash flow margin	113.4%	Revenue: 649949 Open source Operating Cash Flow: 736882 Open source Capital Expenditure: 0 Open source
19961996-06-30	Free cash flow margin	-94.6%	Revenue: 562161 Open source Operating Cash Flow: -525983 Open source Capital Expenditure: 5569 Open source
19971997-06-30	Free cash flow margin	1,005.9%	Revenue: 620180 Open source Operating Cash Flow: 6267437 Open source Capital Expenditure: 29163 Open source
19981998-06-30	Free cash flow margin	-26%	Revenue: 555205 Open source Operating Cash Flow: -140500 Open source Capital Expenditure: 3926 Open source
19991999-06-30	Free cash flow margin	593.3%	Revenue: 336752 Open source Operating Cash Flow: 2002447 Open source Capital Expenditure: 4649 Open source
20002000-06-30	Free cash flow margin	Not reported	Revenue: 555205 Open source Operating Cash Flow: -140500 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -140.5K 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-06-30	Operating cash flow	736882	Operating Cash Flow: 736882 Open source
19961996-06-30	Operating cash flow	-525983	Operating Cash Flow: -525983 Open source
19971997-06-30	Operating cash flow	6267437	Operating Cash Flow: 6267437 Open source
19981998-06-30	Operating cash flow	-140500	Operating Cash Flow: -140500 Open source
19991999-06-30	Operating cash flow	2002447	Operating Cash Flow: 2002447 Open source
20002000-06-30	Operating cash flow	-140500	Operating Cash Flow: -140500 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 2M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-06-30	Free cash flow	736882	Operating Cash Flow: 736882 Open source Capital Expenditure: 0 Open source
19961996-06-30	Free cash flow	-531552	Operating Cash Flow: -525983 Open source Capital Expenditure: 5569 Open source
19971997-06-30	Free cash flow	6238274	Operating Cash Flow: 6267437 Open source Capital Expenditure: 29163 Open source
19981998-06-30	Free cash flow	-144426	Operating Cash Flow: -140500 Open source Capital Expenditure: 3926 Open source
19991999-06-30	Free cash flow	1997798	Operating Cash Flow: 2002447 Open source Capital Expenditure: 4649 Open source
20002000-06-30	Free cash flow	Unavailable	Operating Cash Flow: -140500 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-06-30	Liabilities / assets	Not reported	No source recorded
1996-06-30	Liabilities / assets	Not reported	Total Assets: 659799 Open source
1997-06-30	Liabilities / assets	Not reported	Total Assets: 15757861 Open source
1998-06-30	Liabilities / assets	Not reported	Total Assets: 12999481 Open source
1999-06-30	Liabilities / assets	Not reported	Total Assets: 13102797 Open source
2000-06-30	Liabilities / assets	Not reported	Total Assets: 10076918 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

17.94× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-06-30	Current assets / current liabilities	3.07×	Current Assets: 1050928 Open source Current Liabilities: 342286 Open source
19961996-06-30	Current assets / current liabilities	1.17×	Current Assets: 601986 Open source Current Liabilities: 512762 Open source
19971997-06-30	Current assets / current liabilities	5.82×	Current Assets: 9428290 Open source Current Liabilities: 1621084 Open source
19981998-06-30	Current assets / current liabilities	7.97×	Current Assets: 9207222 Open source Current Liabilities: 1154850 Open source
19991999-06-30	Current assets / current liabilities	9.79×	Current Assets: 12102136 Open source Current Liabilities: 1235620 Open source
20002000-06-30	Current assets / current liabilities	17.94×	Current Assets: 10076918 Open source Current Liabilities: 561782 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1994-07-01 – 1995-06-30	USD 279,276 Exact value Exact value: 279276 USD 1994-07-01 – 1995-06-30: 279276 USD Inspect Net Income Open source Share or cite Citation for Net Income · CISTRON BIOTECHNOLOGY INC · 1995-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Net Income: 279276 USD Concept: fundies:NetIncome Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ANetIncome&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:NetIncome: 279276 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-97-000017.txt#1941 The citation records this snapshot. The page link may show a newer release later.	USD 736,882 Exact value Exact value: 736882 USD 1994-07-01 – 1995-06-30: 736882 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CISTRON BIOTECHNOLOGY INC · 1995-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Operating Cash Flow: 736882 USD Concept: fundies:OperatingCashFlow Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3AOperatingCashFlow&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 736882 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-97-000017.txt#1961 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1994-07-01 – 1995-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CISTRON BIOTECHNOLOGY INC · 1995-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ACapitalExpenditure&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-97-000017.txt#1923 The citation records this snapshot. The page link may show a newer release later.	USD 736,882 Calculation and evidence 736882 − 0 USD Exact free cash flow: 736882 USD 1994-07-01 – 1995-06-30: 736882 USD · Inspect Operating Cash Flow · Source 1994-07-01 – 1995-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CISTRON BIOTECHNOLOGY INC · 1995-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Free cash flow: 736882 USD Concept: free-cash-flow Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 736882 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-97-000017.txt#1961 Input fundies:CapitalExpenditure: 0 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-97-000017.txt#1923 The citation records this snapshot. The page link may show a newer release later.
1996 1995-07-01 – 1996-06-30	−USD 1.11 million Exact value Exact value: -1106166 USD 1995-07-01 – 1996-06-30: -1106166 USD Inspect Net Income Open source Share or cite Citation for Net Income · CISTRON BIOTECHNOLOGY INC · 1996-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Net Income: -1106166 USD Concept: fundies:NetIncome Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ANetIncome&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1106166 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-98-000011.txt#2202 The citation records this snapshot. The page link may show a newer release later.	−USD 525,983 Exact value Exact value: -525983 USD 1995-07-01 – 1996-06-30: -525983 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CISTRON BIOTECHNOLOGY INC · 1996-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Operating Cash Flow: -525983 USD Concept: fundies:OperatingCashFlow Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3AOperatingCashFlow&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -525983 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-98-000011.txt#2224 The citation records this snapshot. The page link may show a newer release later.	USD 5,569 Exact value Exact value: 5569 USD 1995-07-01 – 1996-06-30: 5569 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CISTRON BIOTECHNOLOGY INC · 1996-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Capital Expenditure: 5569 USD Concept: fundies:CapitalExpenditure Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ACapitalExpenditure&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5569 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-98-000011.txt#2183 The citation records this snapshot. The page link may show a newer release later.	−USD 531,552 Calculation and evidence -525983 − 5569 USD Exact free cash flow: -531552 USD 1995-07-01 – 1996-06-30: -525983 USD · Inspect Operating Cash Flow · Source 1995-07-01 – 1996-06-30: 5569 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CISTRON BIOTECHNOLOGY INC · 1996-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Free cash flow: -531552 USD Concept: free-cash-flow Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -525983 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-98-000011.txt#2224 Input fundies:CapitalExpenditure: 5569 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-98-000011.txt#2183 The citation records this snapshot. The page link may show a newer release later.
1997 1996-07-01 – 1997-06-30	USD 12.35 million Exact value Exact value: 12345954 USD 1996-07-01 – 1997-06-30: 12345954 USD Inspect Net Income Open source Share or cite Citation for Net Income · CISTRON BIOTECHNOLOGY INC · 1997-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Net Income: 12345954 USD Concept: fundies:NetIncome Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ANetIncome&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:NetIncome: 12345954 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2472 The citation records this snapshot. The page link may show a newer release later.	USD 6.27 million Exact value Exact value: 6267437 USD 1996-07-01 – 1997-06-30: 6267437 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CISTRON BIOTECHNOLOGY INC · 1997-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Operating Cash Flow: 6267437 USD Concept: fundies:OperatingCashFlow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3AOperatingCashFlow&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6267437 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496 The citation records this snapshot. The page link may show a newer release later.	USD 29,163 Exact value Exact value: 29163 USD 1996-07-01 – 1997-06-30: 29163 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CISTRON BIOTECHNOLOGY INC · 1997-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Capital Expenditure: 29163 USD Concept: fundies:CapitalExpenditure Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ACapitalExpenditure&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29163 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2452 The citation records this snapshot. The page link may show a newer release later.	USD 6.24 million Calculation and evidence 6267437 − 29163 USD Exact free cash flow: 6238274 USD 1996-07-01 – 1997-06-30: 6267437 USD · Inspect Operating Cash Flow · Source 1996-07-01 – 1997-06-30: 29163 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CISTRON BIOTECHNOLOGY INC · 1997-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Free cash flow: 6238274 USD Concept: free-cash-flow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6267437 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496 Input fundies:CapitalExpenditure: 29163 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2452 The citation records this snapshot. The page link may show a newer release later.
1998 1997-07-01 – 1998-06-30	−USD 476,479 Exact value Exact value: -476479 USD 1997-07-01 – 1998-06-30: -476479 USD Inspect Net Income Open source Share or cite Citation for Net Income · CISTRON BIOTECHNOLOGY INC · 1998-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Net Income: -476479 USD Concept: fundies:NetIncome Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ANetIncome&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:NetIncome: -476479 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2472 The citation records this snapshot. The page link may show a newer release later.	−USD 140,500 Exact value Exact value: -140500 USD 1997-07-01 – 1998-06-30: -140500 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CISTRON BIOTECHNOLOGY INC · 1998-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Operating Cash Flow: -140500 USD Concept: fundies:OperatingCashFlow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3AOperatingCashFlow&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -140500 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496 The citation records this snapshot. The page link may show a newer release later.	USD 3,926 Exact value Exact value: 3926 USD 1997-07-01 – 1998-06-30: 3926 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CISTRON BIOTECHNOLOGY INC · 1998-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Capital Expenditure: 3926 USD Concept: fundies:CapitalExpenditure Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ACapitalExpenditure&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3926 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2452 The citation records this snapshot. The page link may show a newer release later.	−USD 144,426 Calculation and evidence -140500 − 3926 USD Exact free cash flow: -144426 USD 1997-07-01 – 1998-06-30: -140500 USD · Inspect Operating Cash Flow · Source 1997-07-01 – 1998-06-30: 3926 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CISTRON BIOTECHNOLOGY INC · 1998-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Free cash flow: -144426 USD Concept: free-cash-flow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -140500 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496 Input fundies:CapitalExpenditure: 3926 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2452 The citation records this snapshot. The page link may show a newer release later.
1999 1998-07-01 – 1999-06-30	−USD 277,164 Exact value Exact value: -277164 USD 1998-07-01 – 1999-06-30: -277164 USD Inspect Net Income Open source Share or cite Citation for Net Income · CISTRON BIOTECHNOLOGY INC · 1999-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Net Income: -277164 USD Concept: fundies:NetIncome Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ANetIncome&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:NetIncome: -277164 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2472 The citation records this snapshot. The page link may show a newer release later.	USD 2 million Exact value Exact value: 2002447 USD 1998-07-01 – 1999-06-30: 2002447 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CISTRON BIOTECHNOLOGY INC · 1999-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Operating Cash Flow: 2002447 USD Concept: fundies:OperatingCashFlow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3AOperatingCashFlow&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2002447 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496 The citation records this snapshot. The page link may show a newer release later.	USD 4,649 Exact value Exact value: 4649 USD 1998-07-01 – 1999-06-30: 4649 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CISTRON BIOTECHNOLOGY INC · 1999-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Capital Expenditure: 4649 USD Concept: fundies:CapitalExpenditure Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ACapitalExpenditure&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4649 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2452 The citation records this snapshot. The page link may show a newer release later.	USD 2 million Calculation and evidence 2002447 − 4649 USD Exact free cash flow: 1997798 USD 1998-07-01 – 1999-06-30: 2002447 USD · Inspect Operating Cash Flow · Source 1998-07-01 – 1999-06-30: 4649 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CISTRON BIOTECHNOLOGY INC · 1999-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Free cash flow: 1997798 USD Concept: free-cash-flow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2002447 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2496 Input fundies:CapitalExpenditure: 4649 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-99-000013.txt#2452 The citation records this snapshot. The page link may show a newer release later.
2000 1999-07-01 – 2000-06-30	−USD 476,479 Exact value Exact value: -476479 USD 1999-07-01 – 2000-06-30: -476479 USD Inspect Net Income Open source Share or cite Citation for Net Income · CISTRON BIOTECHNOLOGY INC · 2000-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Net Income: -476479 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -476479 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-00-000017.txt#2547 The citation records this snapshot. The page link may show a newer release later.	−USD 140,500 Exact value Exact value: -140500 USD 1999-07-01 – 2000-06-30: -140500 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CISTRON BIOTECHNOLOGY INC · 2000-06-30 CISTRON BIOTECHNOLOGY INC (edgar:793725) Operating Cash Flow: -140500 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T14:53:52Z Snapshot: fd45dea87503e038645811d0a6ba6caca2c54612386616c8e9fde35676ac20c8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/793725/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -140500 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/793725/0000793725-00-000017.txt#2572 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000793725, 793725, edgar:793725

CISTRON BIOTECHNOLOGY INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2000 1999-07-01 – 2000-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation